U.S., Sweden sign cancer research and innovation pact as part of preparedness plan for potential Russian aggression March 22, 2024Vol.50 No.12By Matthew Bin Han Ong
Cancer History ProjectConversation with The Cancer LetterFree Weeks before death from sarcoma, Norm Coleman reflected on his career in radiation oncology and addressing health disparities March 22, 2024Vol.50 No.12By Otis W. Brawley, Alexandria Carolan and Paul Goldberg
FreeGuest Editorial The global health contributions of Norm Coleman March 22, 2024Vol.50 No.12By Nina Wendling and Donna M. O’Brien
Drugs & Targets Tempus contributes de-identified cancer data to NCI’s planned data enclave March 22, 2024Vol.50 No.12
White House Biden’s FY25 budget requests $522M increase for NCI, $1.5B for ARPA-H, $2.9B for Moonshot March 15, 2024Vol.50 No.11By Alexandria Carolan
In Brief Rutgers Cancer Institute redesignated as NCI Comprehensive Cancer Center March 08, 2024Vol.50 No.10
In Brief President’s Cancer Panel recommends five priority areas for the National Cancer Plan March 01, 2024Vol.50 No.09
Drugs & Targets Lixte Biotechnology enters exclusive immuno-oncology patent license agreement with NINDS, NCI March 01, 2024Vol.50 No.09
First-ever commercial TIL therapy: How NCI, Iovance, and Moffitt achieved FDA approval February 23, 2024Vol.50 No.08By Matthew Bin Han Ong
